Lactate Dehydrogenase Levels after Aortic Valve Replacement: What Do They Tell Us?

Introduction:  Lactate dehydrogenase (LDH) is a standard postoperative marker for hemolysis in the presence of paravalvular leakage (PVL) after replacement of the aortic valve (AVR). LDH is elevated in certain valves by a fluttering phenomenon. Previous studies suggested a correlation between microparticles (MPs) and LDH elevation after AVR.

Catheter-related Complications of Subcutaneous Implantable Venous Access Devices in Breast Cancer Patients.

Background/aim: Totally implanted venous access devices (TIVAD) are increasingly used in the treatment of cancer patients. The aim of this study was to assess the incidence of early and late complications resulting from subcutaneous TIVADs in patients with breast cancer.

Materials And Methods: Between 2004 and 2009, we reviewed patients with breast cancer who had a TIVAD placed.

SATB1 gene expression and breast cancer prognosis.

Recently it has been shown that the genome organizer SATB1 plays an important role in breast cancer progression and predicts a poor prognosis. However its prognostic value compared to markers as the estrogen receptor is currently unclear. The expression levels of SATB1 mRNA from Affymetrix microarray in a cohort of 2058 breast cancer samples and its prognostic impact were analyzed.

New transobturator sling for less invasive treatment of urinary incontinence in women--SERASIS TO.

Urinary incontinence, defined as a leakage of small amounts of urine during physical movement (coughing, sneezing, exercising) is rather a common problem. The treatment of this disorder is even more non-uniformed: there have been roundly 100 operations proposed for it. The Burch procedure has become probably the most popular.